Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF in Asymptomatic Recurrent Ovarian Cancer
NCT00157573Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2004
- Primary completion
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of sargramostim in ovarian cancer, primary peritoneal carcinoma (PPC), fallopian tube cancer (PFTC), sponsored by Massachusetts General Hospital. Started Dec 2004; status: completed.
02
Drugs
sargramostim
03
Conditions
ovarian cancerprimary peritoneal carcinoma (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT00157573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157573.